Click chemistry for [99mTc(CO)3] labeling of Lys3-bombesin

Applied Radiation and Isotopes

Volumn 68, Issue 12, 2010, Pages 2274-2278

  Ferro Flores, G ^a   Rivero, I A ^a,b   Santos Cuevas, C L ^a,c   Sarmiento, J I ^b   Arteaga de Murphy, C ^d   Ocampo Garcia B E ^a   Garcia Becerra R ^d   Ordaz Rosado, D ^d  

^a INSTITUTO NACIONAL DE INVESTIGACIONES NUCLEARES   (Mexico)

^b TIJUANA INSTITUTE OF TECHNOLOGY   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MÉXICO   (Mexico)

^d INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

99mTc labeled bombesin; 99mTc tricarbonyl triazole Lys3 bombesin; Click chemistry; Radiolabeled Lys3 bombesin

Indexed keywords

99MTC LABELED BOMBESIN; 99MTC-TRICARBONYL-TRIAZOLE-LYS3-BOMBESIN; BIODISTRIBUTIONS; CANCER CELLS; CLICK CHEMISTRY; FUNCTIONALIZATIONS; HEPATOBILIARY; IN-VITRO; IN-VIVO; LIPOPHILICITY; MCF-7 BREAST CANCER CELLS; PEPTIDE RECEPTOR; RADIOLABELED LYS3-BOMBESIN; SPECIFIC BINDING; SPECIFIC RECOGNITION;

CELLS; NITROGEN COMPOUNDS;

PEPTIDES;

GASTRIN RELEASING PEPTIDE RECEPTOR; RADIOPHARMACEUTICAL AGENT; TRICARBONYLTRIAZOLE LYSINE 3 BOMBESIN TC M99; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG SPECIFICITY; DRUG STRUCTURE; DRUG UPTAKE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; LIPOPHILICITY; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOCHEMISTRY;

ANIMALS; BOMBESIN; CELL LINE, TUMOR; HUMANS; MICE; ORGANOTECHNETIUM COMPOUNDS;

EID: 77956404523     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2010.06.014     Document Type: Article

References (27)

1. Alberto R. New organometallic technetium complexes for radiopharmaceutical imaging. Contrast Agents III: Radiopharmaceuticals from Diagnostics to Therapeutics 2005, vol. 252. Springer, Berlin, pp. 1-44.
2. Baidoo K.E., Lin K.S., Zhan Y., Finley P., Scheffel U., Wagner H.N. Design, synthesis, and initial evaluation of high-affinity technetium bombesin analogues. Bioconjugate Chem. 1998, 9:218.
3. 99mTc: a reflection on technetium core structures and a strategy for new chelate design. Nucl. Med. Biol. 2005, 32:1.
4. Best M.D. Click chemistry and bioorthogonal reactions: unprecedented selectivity in the labeling of biological molecules. Biochemistry 2009, 48:6571.
5. 3]-bombesin for imaging of GRP receptor-positive tumours. Nucl. Med. Commun. 2006, 27:371.
6. 3 bombesin analogues. Nucl. Med. Biol. 2007, 34:17.
7. Garcia-Garayoa E., Schweinsberg C., Maes V., Ruegg D., Blanc A., Blauenstein P., Tourwe D.A., Beck-Sickinger A.G., Schubiger P.A. New [Tc-99m]bombesin analogues with improved biodistribution for targeting gastrin releasing peptide receptor-positive tumors. Q. J. Nucl. Med. Mol. Imaging 2007, 51:42.
8. - core. Bioconjugate Chem. 2008, 19:2409.
9. 3-Octreotide prepared from lyophilized kits. Appl. Rad. Isot. 2006, 64:792.
10. Kolb H.C., Finn M.G., Sharpless K.B. Click chemistry: diverse chemical function from a few good reactions. Angew. Chem. Int. Ed. 2001, 40:2004.
11. Krasinski A., Fokin V.V., Sharpless K.B. Direct synthesis of 1,5-disubstituted-4-magnesio-1,2,3-triazoles, revisited. Org. Lett. 2004, 6:1237.
12. 99mTc(I)-labeled bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors. Nucl. Med. Biol. 2002, 29:553.
13. Mindt T.L., Struthers H., Brans L., Anguelov T., Schweinsberg C., Maes V., Tourw D., Schibli R. "Click to chelate": synthesis and installation of metal chelates into biomolecules in a single step. J. Am. Chem. Soc. 2006, 128:15096.
14. 99mTc-pteroate radiotracers for folate receptor-positive tumour targeting. Eur. J. Nucl. Med. Mol. Imaging 2006, 33:1007.
15. +. Chem. A Eur. J. 2003, 9:2053.
16. Prasuhn D.E., Yeh R.M., Obenaus A., Manchester M., Finn M.G. Viral MRI contrast agents: coordination of Gd by native virions and attachment of Gd complexes by azide-alkyne cycloaddition. Chem. Commun. 2007, 1269.
17. 2(NO)"-complexes provide new pathways for bioorganometallic chemistry. J. Organomet. Chem. 2004, 689:4833.
18. Reubi J.C. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocrine Rev. 2003, 24:389-427.
19. 3]-bombesin: biokinetics and dosimetry in women. Nucl. Med. Commun. 2008, 29:741.
20. 2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical. Int. J. Pharm. 2009, 375:75.
21. 99mTc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules. Bioconjugate Chem. 2000, 11:345.
22. - labeled bombesin analogues for improved targeting of gastrin-releasing peptide receptor-positive tumors. Bioconjugate Chem. 2008, 19:2432.
23. 2]: synthesis, radiolabeling and in vitro/in vivo GRP receptor targeting studies. Anticancer Res. 2003, 23:63.
24. Tornoe C.W., Christensen C., Meldal M. Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(I)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. J. Org. Chem. 2002, 67:3057.
25. 5]-enkephalin with organometallic Mo complexes by solid-phase synthesis. Chem. Commun. 2002, 1406.
26. 3]-octreotide, a somatostatin analog for tumor diagnosis. J. Pharm. Sci. 2004, 93:2497.
27. Wu P., Fokin V.V. Catalytic azide-alkyne cycloaddition: reactivity and applications. Aldrichim. Acta 2007, 40:7.